MARCY L’ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a global leader in the field of in vitro diagnostics, today released its business review for the first six months of 2007. Because the first half of the Company’s fiscal year began before January 20, 2007, this interim review has been prepared in narrative form, in line with Autorité des Marchés Financiers guidance on the application of article L 451-1-2 of the Monetary and Financial Code.
